BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 42 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $64,338 | +22.2% | 45,956 | -2.2% | 0.00% | – |
| Q4 2023 | $52,648 | +12.5% | 47,007 | +4.5% | 0.00% | – |
| Q3 2023 | $46,782 | -67.9% | 44,983 | -60.5% | 0.00% | – |
| Q2 2023 | $145,906 | +42687.7% | 113,989 | -53.6% | 0.00% | – |
| Q1 2023 | $341 | +7.9% | 245,411 | +0.8% | 0.00% | – |
| Q4 2022 | $316 | -99.8% | 243,401 | +105.6% | 0.00% | – |
| Q3 2022 | $175,000 | -55.2% | 118,379 | -38.3% | 0.00% | – |
| Q2 2022 | $391,000 | -81.1% | 191,856 | +17.6% | 0.00% | -100.0% |
| Q3 2021 | $2,064,000 | +317.8% | 163,131 | +410.2% | 0.00% | – |
| Q2 2021 | $494,000 | – | 31,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $29,242,000 | 11.52% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $18,041,000 | 5.60% |
| Novo Holdings A/S | 4,503,991 | $69,632,000 | 3.09% |
| Vivo Capital, LLC | 3,871,291 | $59,850,000 | 2.59% |
| Sofinnova Investments, Inc. | 2,754,437 | $42,584,000 | 2.45% |
| Ally Bridge Group (NY) LLC | 412,267 | $6,374,000 | 1.58% |
| Samsara BioCapital, LLC | 737,459 | $11,401,000 | 1.41% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $11,125,000 | 1.04% |
| RA Capital Management | 2,378,325 | $36,769,000 | 0.59% |
| Rock Springs Capital Management LP | 1,619,248 | $25,034,000 | 0.50% |